Lir Life Sciences Corp. (CVE:SKNY) | WebDisclosure

Basculer en Français

10247	Companies
211679	Keywords
141594	Articles
112138	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

BRIEF

published on 04/21/2026 at 00:05, 5 hours 26 minutes ago

LIR Life Sciences Corp. s'associe à Resilience BioSciences Inc.

Recherche Préclinique Collaboration Technologique Développement De Médicaments Nouvelles Thérapies Environnement Académique
BRIEF

published on 04/21/2026 at 00:05, 5 hours 26 minutes ago

LIR Life Sciences Corp. Partners with Resilience BioSciences Inc.

Drug Development Preclinical Research Technology Collaboration Novel Therapies Academic Environment
PRESS RELEASE

published on 04/21/2026 at 00:00, 5 hours 31 minutes ago

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
LIR Life Sciences Corp. announces a Technology Development Collaboration Agreement with Resilience BioSciences Inc. to enhance preclinical research activities in drug discovery and development

Drug Discovery Life Sciences Collaboration Agreement Preclinical Research Resilience BioSciences
BRIEF

published on 02/06/2026 at 00:05, 2 months 15 days ago

LIR Life Sciences lance la phase 2 de la conception de peptides avec Neuland Laboratories

Administration Transdermique LIR Sciences De La Vie Laboratoires Neuland Conception De Peptides Relations Structure-activité
BRIEF

published on 02/06/2026 at 00:05, 2 months 15 days ago

LIR Life Sciences Initiates Phase 2 Peptide Design with Neuland Laboratories

Transdermal Delivery LIR Life Sciences Neuland Laboratories Peptide Design Structure-Activity Relationships
PRESS RELEASE

published on 02/06/2026 at 00:00, 2 months 15 days ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
LIR Life Sciences Corp. announces commencement of Project Phase 2 peptide design activities with Neuland Laboratories Limited, focusing on next-generation cell-penetrating peptides for transdermal delivery platform optimization

Transdermal Delivery Lir Life Sciences Corp. Peptide Design Project Phase 2 Neuland Laboratories Limited
BRIEF

published on 01/30/2026 at 00:05, 2 months 22 days ago

LIR Life Sciences annonce des résultats précliniques intermédiaires prometteurs

Administration Transdermique Résultats Précliniques Thérapies GLP/GIP Technologie CPP Contrôle De La Glycémie
BRIEF

published on 01/30/2026 at 00:05, 2 months 22 days ago

LIR Life Sciences Reports Promising Interim Preclinical Results

Transdermal Delivery Preclinical Results GLP/GIP Therapies CPP Technology Blood Glucose Control
PRESS RELEASE

published on 01/30/2026 at 00:00, 2 months 22 days ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
LIR Life Sciences Corp. announces positive interim results from a mouse study on CPP-enabled, needle-free delivery of GLP/GIP therapies, demonstrating glucose control potential

Interim Results Lir Life Sciences Corp. GLP/GIP Therapies CPP-enabled Delivery Skin-applied Formulation
BRIEF

published on 01/23/2026 at 00:05, 2 months 29 days ago

LIR Life Sciences Finalizes Study Design for Evaluating Transdermal Agents

Transdermal Delivery LIR Life Sciences Therapeutic Macromolecules Porcine Skin Model Needle-free Therapies

1 2 ... 4

Accesswire

Published on 04/21/2026 at 01:05, 4 hours 26 minutes ago

Boron One Holdings Inc. Announces Closing of Financing
Published on 04/21/2026 at 00:00, 5 hours 31 minutes ago

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
Published on 04/20/2026 at 23:50, 5 hours 41 minutes ago

Waskahigan Oil & Gas Corp. Provides Corporate Update
Published on 04/20/2026 at 22:15, 7 hours 16 minutes ago

Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Published on 04/20/2026 at 15:25, 14 hours 6 minutes ago

Banyan Gold Announces $46.5 Million Private Placement

View all ACCESSWIRE

EQS Group

Published on 04/21/2026 at 02:05, 3 hours 26 minutes ago

Remi Preemptively Deploys Programmable Compliance Architecture, Fully Aligned with HKMA's Latest Stablecoin Licensing Standards
Published on 04/20/2026 at 22:05, 7 hours 26 minutes ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 11 mai 2026 - Mise à disposition des documents préparatoires
Published on 04/20/2026 at 22:05, 7 hours 26 minutes ago

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Published on 04/20/2026 at 19:00, 10 hours 31 minutes ago

PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 13 avril 2026 au 17 avril 2026
Published on 04/20/2026 at 18:59, 10 hours 32 minutes ago

EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback

Les Echos

Published on 04/20/2026 at 20:44, 8 hours 47 minutes ago

ENGIE - Implementation of share buyback programme
Published on 04/20/2026 at 20:44, 8 hours 47 minutes ago

ENGIE - Mise en œuvre de son programme de rachat d'actions
Published on 04/20/2026 at 20:01, 9 hours 30 minutes ago

TERACT - Approval by the AMF of the public buy out offer followed by a squeeze-out of TERACT shares
Published on 04/20/2026 at 20:01, 9 hours 30 minutes ago

TERACT - Communiqué TERACT mise à disposition NR et DAI
Published on 04/20/2026 at 20:01, 9 hours 30 minutes ago

TERACT - Approbation par l’AMF de l’offre publique de retrait suivie d’un retrait obligatoire sur les titres de TERACT

View all LES ECHOS COMFI WIRE